Insight into the Structure and Physicochemical Properties of Potent Chemokine Receptor 5 Inhibitors for the Discovery of Novel Alzheimer’s Disease Drugs
Background: In Alzheimer’s Disease (AD), chemokines recruit pro-inflammatory me-diators and increase the aggregation of both Aβ (amyloid-β) plaque and neurofibrillary tangles (NFTs). Chemokine receptor 5 (CCR5) has been demonstrated to be involved in neuroinflamma-tion and neuroimmunology, where its...
Published in: | Central Nervous System Agents in Medicinal Chemistry |
---|---|
Main Author: | Yusof N.I.S.M.; Awaluddin N.A.; Fauzi F.M. |
Format: | Article |
Language: | English |
Published: |
Bentham Science Publishers
2023
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85172425864&doi=10.2174%2f1871524923666230726102846&partnerID=40&md5=b745acb10d4f6855f36774a6a420297f |
Similar Items
-
Synthesis and biological evaluation of novel coumarin derivatives bearing sulfonamide moiety as potent α-glucosidase inhibitors
by: Alsukor A.; Inayatsyah N.A.; Ridhwan M.J.M.; Kasim N.; Imran S.
Published: (2025) -
Bromophenols from Symphyocladia latiuscula (Harvey) Yamada as Novel Cholecystokinin 2 Receptor Antagonists
by: Paudel P.; Park S.E.; Seong S.H.; Fauzi F.M.; Jung H.A.; Choi J.S.
Published: (2023) -
Advancing Parkinson's disease biopathology and drug discovery by dual cellular modelling
by: Chua P.; Ulfa Seruji N.M.; Lizazman M.A.; Mian Jong V.Y.; Lim W.K.
Published: (2024) -
Synthesis of oxadiazole-coupled-thiadiazole derivatives as a potent β-glucuronidase inhibitors and their molecular docking study
by: Taha M.; Imran S.; Alomari M.; Rahim F.; Wadood A.; Mosaddik A.; Uddin N.; Gollapalli M.; Alqahtani M.A.; Bamarouf Y.A.
Published: (2019) -
Reverse pharmacophore mapping and molecular docking studies for discovery of GTPase HRas as promising drug target for bis-pyrimidine derivatives
by: Kumar S.; Singh J.; Narasimhan B.; Shah S.A.A.; Lim S.M.; Ramasamy K.; Mani V.
Published: (2018)